Lapatinib Tablet

Tykerb Tablet contains Lapatinib ditosylate 250 mg is used for the treatment of advanced or metastatic breast cancer.Tykerb (chemical name: Lapatinib) has been approved by the U.S. Food and Drug Administration (FDA).To be given in combination with, a type of chemotherapy to treat advanced-stage, HER2-positive breast cancer that has stopped responding to anthracyclines or taxanes.